GENOMMA LAB INTERNACIONAL SAB ( GNMLF) - Stock Earnings
GNMLF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | 1.4 million USD | 14.9 million USD |
| 2023Q3 | 1.2 million USD | 14.5 million USD |
| 2023Q4 | -400665 USD | 12.2 million USD |
GNMLF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | 3.1 million USD | 36.8 million USD |
| 2022 | 3.7 million USD | 44.3 million USD |
| 2023 | 3.6 million USD | 57.1 million USD |
GNMLF
Price: $0.92
Dividend Yield: 5.20%
Forward Dividend Yield: 85.25%
Payout Ratio: 871.47%
Dividend Per Share: 0.78 USD
Earnings Per Share: 0.09 USD
P/E Ratio: 10.40
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 954.3 million
Average Dividend Frequency: 5
Years Paying Dividends: 4